Good responses but high TRM in adult patients after MSC therapy for GvHD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Good responses but high TRM in adult patients after MSC therapy for GvHD

Published:2016-12-12 Issue:4 Volume:52 Page:606-608
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Salmenniemi U,Itälä-Remes M,Nystedt J,Putkonen M,Niittyvuopio R,Vettenranta K,Korhonen M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2016317.pdf

Reference14 articles.

1. Levine JE, Hogan WJ, Harris AC, Litzow MR, Efebera YA, Devine SM et al. Improved accuracy of acute graft-versus-host disease staging among multiple centers. Best Pract Res Clin Haematol 2014; 27: 283–287.

2. Ferrara JLM, Levine JE, Reddy P, Holler E . Graft-versus-host disease. Lancet 2009; 373: 1550–1561.

3. Cahn J-Y, Klein JP, Lee SJ, Milpied NM, Blaise D, Antin JH et al. Prospective evaluation of 2 acute graft-versus-host (GvHD) grading system: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI) and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood 2005; 106: 1495–1450.

4. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295–304.

5. Jagasia M, Greinix H, Arora M, Williams K, Wolff D, Cowen W et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and staging working group report. Biol Blood Marrow Transplant 2015; 21: 389–401.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human umbilical cord-derived mesenchymal stromal cells for the treatment of steroid refractory grades III-IV acute graft-versus-host disease with long-term follow-up;Frontiers in Immunology;2024-08-15

2. International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges;Cytotherapy;2024-05

3. Mesenchymal Stem Cell Applications in Graft Versus Host Disease;Turkish Journal of Pediatric Disease;2024-02-19

4. Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease;Stem Cells;2024-01-10

5. Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: Promises, problems and prospects;Medicinal Research Reviews;2023-12-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3